Why Trump’s battle isn’t over

Good evening. I’m Soumya Karlamangla, and it’s Monday, Oct. 5. Here’s what’s happening with the coronavirus in California and beyond.

After a chaotic weekend of conflicting information about President Trump’s battle with COVID-19, the First Patient headed home from Walter Reed National Military Medical Center on Monday evening.

His departure came just three days after he was hospitalized for COVID-19. During that time, he received supplemental oxygen, remdesevir and dexamethasone, medicines typically reserved for the sickest of patients. That Trump was given these treatments so soon after his positive test result was announced raised questions about when the president actually fell sick, when he was first diagnosed, and how serious his symptoms were. Those questions remain unanswered.

Trump and some of his staff maintain that his symptoms are mild. On Sunday, he staged a motorcade drive-by to wave at his supporters lined up outside Walter Reed. On

Read More

Trump says insulin is now so cheap, it’s ‘like water.’ It isn’t

President Trump made a number of claims about lowering drug prices during his debate with Democratic challenger Joe Biden. Most were untrue. <span class="copyright">(Arkasha Stevenson / Los Angeles Times)</span>
President Trump made a number of claims about lowering drug prices during his debate with Democratic challenger Joe Biden. Most were untrue. (Arkasha Stevenson / Los Angeles Times)

There was much to dislike in this week’s presidential debate — the lies, the rudeness, the inability of the White House incumbent to rise above the level of a cranky kindergartner.

For me, the low point came not when President Trump refused to condemn white supremacy, and not when he tore into the sons of Democratic candidate Joe Biden, but when he once again sought to convince the American people that he had single-handedly lowered the cost of prescription drugs.

Trump claimed that drug prices “will be coming down 80% or 90%” thanks to him.

He claimed that a series of executive orders have forced pharmaceutical companies to slash prices.

And the one that floored me: Trump claimed that the cost of

Read More

Trump promised 300 million N95 masks by September. He isn’t even close.

WASHINGTON — The Trump administration is falling far short of its goal of having 300 million N95 respirators available in time for the flu season, according to internal documents reviewed by Yahoo News. Though the supply of N95 respirators has greatly increased in the last several months, it is at a little less than one-third of promised levels.

N95 respirators protect wearers against the coronavirus better than cloth or surgical face masks; the name refers to their ability to filter out 95 percent, or all but the smallest, of particles. The masks are critical to people in medical settings and frontline occupations.

According to a briefing document circulated on Monday to senior officials in the Department of Health and Human Services, the government now has 87.6 million N95 masks available, far short of the 300 million promised several months ago. 

The administration has also stockpiled 49 million KN95 masks, which

Read More

Primary Care Isn’t Bouncing Back

Primary care is not bouncing back to its pre-pandemic status, according to a new survey published by the Primary Care Collaborative (PCC) and Larry A. Green Center. 

Since mid-March these organizations have issued short weekly and biweekly surveys to US primary care physicians in an attempt to find the pulse of the county’s first line of care. “There is not a federal office for primary care, and it’s been anemically funded for decades,” Rebecca Etz, PhD, told Medscape Medical News. Yet these clinics represent the front lines of US healthcare, and it’s where most Americans go for care and COVID-19 care, said Etz, director of the Virginia-based Larry A. Green Center, which is devoted to primary care research, development, and advocacy. 

The latest survey responses, collected between September 4 to 6, confirm what researchers had suspected: primary care isn’t on solid footing. Eighty-one percent of respondents disagreed emphatically that

Read More